These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2604293)

  • 21. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.
    Suter S; Chevallier I
    Eur Respir J; 1991 Jan; 4(1):40-9. PubMed ID: 2026237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa colonization in cystic fibrosis: Impact on neutrophil functions and cytokine secretion capacity.
    Aslanhan U; Cakir E; Pur Ozyigit L; Kucuksezer UC; Gelmez YM; Yuksel M; Deniz G; Cetin Aktas E
    Pediatr Pulmonol; 2021 Jun; 56(6):1504-1513. PubMed ID: 33512090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation.
    Black HR; Yankaskas JR; Johnson LG; Noah TL
    Am J Respir Cell Mol Biol; 1998 Aug; 19(2):210-5. PubMed ID: 9698592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children.
    Shmarina GV; Pukhalsky AL; Kokarovtseva SN; Pukhalskaya DA; Shabalova LA; Kapranov NI; Kashirskaja NJ
    Mediators Inflamm; 2001 Aug; 10(4):191-7. PubMed ID: 11577995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
    Croft NM; Marshall TG; Ferguson A
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Elastase-alpha 1-proteinase inhibitor complex (E alpha 1 PI) and lactoferrin plasma concentrations in viral and bacterial infections].
    Tegtmeyer FK; Maacks S; van Wees J; Wood WG
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):96-101. PubMed ID: 2038354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.
    Finn A; Naik S; Klein N; Levinsky RJ; Strobel S; Elliott M
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):234-41. PubMed ID: 8429650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma tumour necrosis factor alpha in cystic fibrosis.
    Norman D; Elborn JS; Cordon SM; Rayner RJ; Wiseman MS; Hiller EJ; Shale DJ
    Thorax; 1991 Feb; 46(2):91-5. PubMed ID: 2014508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.
    Döring G
    Pediatr Pulmonol; 1999 Nov; 28(5):363-75. PubMed ID: 10536068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P; Chignard M
    J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.
    Bédard M; McClure CD; Schiller NL; Francoeur C; Cantin A; Denis M
    Am J Respir Cell Mol Biol; 1993 Oct; 9(4):455-62. PubMed ID: 7691110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.
    Winklhofer-Roob BM; Ellemunter H; Frühwirth M; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Shmerling DH
    Am J Clin Nutr; 1997 Jun; 65(6):1858-66. PubMed ID: 9174484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma interleukin-1 alpha and beta, tumor necrosis factor-alpha, and lipopolysaccharide concentrations during pulmonary exacerbations of cystic fibrosis.
    Wilmott RW; Frenzke M; Kociela V; Peng L
    Pediatr Pulmonol; 1994 Jul; 18(1):21-7. PubMed ID: 7970903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection.
    Elborn JS; Cordon SM; Parker D; Delamere FM; Shale DJ
    Respir Med; 1993 Nov; 87(8):603-7. PubMed ID: 8290744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Konstan MW; Hilliard KA; Norvell TM; Berger M
    Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil elastase inhibitor (ONO-5046.Na) decreases production of proinflammatory cytokines by lipopolysaccharide-stimulated human monocytes.
    Haga Y; Ogawa M
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):243-8. PubMed ID: 9485518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.